Skip to main navigation Skip to search Skip to main content

Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma

  • Tel Aviv Sourasky Medical Center
  • Tel Aviv University
  • Hadassah University Medical Centre

Research output: Contribution to journal › Letter › peer-review

17 Scopus citations
Original languageEnglish
Pages (from-to)e1-e4
JournalBritish Journal of Haematology
Volume192
Issue number1
DOIs
StatePublished - Jan 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • AIHA
  • CLL
  • ITP
  • obinutuzumab

Cite this